Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

FLIP (human) monoclonal antibody (7F10)

 
ALX-804-961-0100 100 µg 422.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:CASPER, CLARP, I-FLICE, Usurpin, CFLAR
 
Clone:7F10
 
Host:Mouse
 
Isotype:IgG1
 
Immunogen:Recombinant human FLIP.
 
UniProt ID:O15519
 
Species reactivity:Human
 
Applications:ELISA, Flow Cytometry, IHC, WB
 
Recommended Dilutions/Conditions:Western Blot (1:500)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Protein G-affinity purified.
 
Formulation:Liquid. In PBS, pH 7.2, containing 50% glycerol and 0.09% sodium azide.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Scientific Background:FLIP contains two death effector domains (DEDs) and a caspase-like domain. FLIP interacts with the adapter protein, FADD, and caspase-8 and –10, and potently inhibits apoptosis induced by death receptors CD95, DR3, TRAIL-R and TNFR1.
 
FLIP (human) monoclonal antibody (7F10) Western blot
Western blot analysis of FLIP (human), mAb (7F10) (Prod. No. ALX-804-961): Lane 1: MW marker, Lane 2&4: HeLa cell lysate, Lane 3&5: Jurkat cell lysate. The two membranes were blotted with 7F10 or NF6 clones at 2µg/ml separately. The result showed they detected very similar pattern in these cell lysates.
Please mouse over
FLIP (human) monoclonal antibody (7F10) Western blot

Product Literature References

The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells: M. Li, et al.; J. Exp. Clin. Cancer Res. 38, 64 (2019), Abstract; Full Text
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP: L. Piggott, et al.; Clin. Cancer Res. 24, 2452 (2018), Abstract;
Differential expression patterns of the short and long isoform of cFLIP on FasL‑mediated apoptosis: H.J. Um, et al.; Oncol. Rep. 39, 2443 (2018), Abstract;
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells: K.K. Kolluri, et al.; Elife 7, e30224 (2018), Abstract; Full Text
Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells: J.H. Jang, et al.; Oncol. Lett. 16, 2030 (2018), Abstract; Full Text
TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment: J.M. Manouchehri, et al.; Breast Cancer (Auckl.) 12, 1178223417749855 (2018), Application(s): Western blot, Abstract; Full Text
Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation: C.M. Henry, et al.; Mol. Cell 65, 715 (2017), Abstract;
cFLIP critically modulates apoptotic resistance in epithelial-to-mesenchymal transition: C. Padmanabhan, et al.; Oncotarget 8, 101072 (2017), Abstract; Full Text
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways: M.C. Tanzer, et al.; Cell Death Differ. 24, 481 (2017), Abstract; Full Text
Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation: R. Gonzalez, et al.; PLoS One 12, e0174326 (2017), Abstract; Full Text
Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24: J. Xu, et al.; J. Cell. Biochem. 117, 1136 (2016), Abstract; Full Text
Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells: M.A. Han, et al.; Sci. Rep. 6, 18642 (2016), Abstract; Full Text
Infection of epithelial cells with Chlamydia trachomatis inhibits TNF-induced apoptosis at the level of receptor internalization while leaving non-apoptotic TNF-signalling intact: C. Waguia Kontchou, et al.; Cell. Microbiol. 18, 1583 (2016), Abstract;
Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover: J.H. Kim, et al.; Int. J. Biochem. Cell Biol. 78, 327 (2016), Application(s): Western blot; cell lysates, Abstract;
YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells: S.M. Woo, et al.; Oncotarget 7, 61520 (2016), Abstract; Full Text
6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression: M.A. Han, et al.; Chem. Biol. Interact. 228, 69 (2015), Abstract;
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients: M.T. Cencioni, et al.; Cell. Death Dis. 6, e1741 (2015), Application(s): Western Blot, Abstract; Full Text
G2/M Arrest Sensitises Erythroid Leukemia Cells to TRAIL-induced Apoptosis: S. Cruet-Hennequart, et al.; J. Leuk. 3, 174 (2015), Application(s): Western Blot, Full Text
Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis: S. Shi, et al.; Oncotarget 6, 1640 (2015), Abstract; Full Text
Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP: W.C. Lin, et al.; Cell Death Dis. 5, e1109 (2014), Application(s): Western blot using human gastric adenocarcinoma cell line AGS, Abstract; Full Text

General Literature References

Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues: T. Imanishi, et al.; Cardiovasc. Res. 48, 101 (2000), Abstract; Full Text

Related Products

FLIP γ/δ (CT) polyclonal antibody 

ICC, WB | Print as PDF
 
ADI-905-226-100 100 µg 374.00 USD
Do you need bulk/larger quantities?
 

c-FLIP polyclonal antibody 

ICC, WB | Print as PDF
 
ADI-AAP-440-E 100 µg 330.00 USD
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
FLIP
By biological activity:
FLIP Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,